ICU Medical (ICUI)
(Delayed Data from NSDQ)
$94.84 USD
+0.31 (0.33%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $94.89 +0.05 (0.05%) 7:58 PM ET
1-Strong Buy of 5 1
B Value D Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ICUI 94.84 +0.31(0.33%)
Will ICUI be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ICUI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ICUI
ICON (ICLR) Q1 Earnings Surpass Estimates, Margins Expand
Align Technology (ALGN) Q1 Earnings Top, 2024 Sales View Up
ICUI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Thermo Fisher (TMO) Q1 Earnings Top Estimates, 2024 View Up
Zacks.com featured highlights include ICU Medical and Ardmore Shipping
ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates
Other News for ICUI
ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call
Commit To Purchase ICU Medical At $70, Earn 10.3% Annualized Using Options
ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum
Insider Sell: COO Christian Voigtlander Sells 13,603 Shares of ICU Medical Inc (ICUI)
ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference